March 18, 2024
RegMed Investors (RMi) Closing Bell: a session of cell and gene therapy sector shifting share pricing
March 15, 2024
RegMed Investors (RMi) Closing Bell: triple witching Friday
March 13, 2024
RegMed Investors (RMi) Closing Bell: drop and give me push-ups, I’ll count until the PPI and jobless claims numbers order
March 12, 2024
RegMed Investors (RMi) Closing Bell: fresh inflation “number” upset daily share pricing response
March 11, 2024
RegMed Investors (RMi) Closing Bell: painful expectation, bracing for U.S. inflation data
March 8, 2024
RegMed Investors (RMi) Closing Bell: a drop the mic (microphone) ending for the sector
March 7, 2024
RegMed Investors (RMi) Closing Bell: drip, drip and drop share pricing
March 6, 2024
RegMed Investors (RMi) Closing Bell: a need for share pricing consistency to retain investors staying power
March 5, 2024
RegMed Investors (RMi) Closing Bell: a black swan versus a white swan; referring to different level of risk
March 1, 2024
RegMed Investors (RMi) Closing Bell: another knee-jerk reaction but, to our advantage
February 29, 2024
RegMed Investors (RMi) Closing Bell: investor jitters
February 28, 2024
RegMed Investors (RMi) Closing Bell: run from sector highs to cash as a portfolio value preservation strategy
February 27, 2024
RegMed Investors (RMi) Closing Bell: a rising tide
February 26, 2024
RegMed Investors (RMi) Closing Bell: bubblicious sentiment?
February 23, 2024
RegMed Investors (RMi) Closing Bell: yesterday’s ups and downs were switching positions
February 22, 2024
RegMed Investors (RMi) Closing Bell: will the “elevation” trend stay a friend?
February 21, 2024
RegMed Investors (RMi) Closing Bell: cell and gene therapy equities closes barely positive
February 20, 2024
RegMed Investors (RMi) Closing Bell: cell and gene therapy equities falter, led by Nasdaq
February 16, 2024
RegMed Investors (RMi) Closing Bell: the cell and gene therapy closed barely positive after a bumpy session
February 15, 2024
RegMed Investors (RMi) Closing Bell: riding the bull
February 14, 2024
RegMed Investors (RMi) Closing Bell: yippee-kai-yay
February 13, 2024
RegMed Investors (RMi) Closing Bell: CPI infused dominoes topple the cell and gene therapy sector
February 12, 2024
RegMed Investors (RMi) Closing Bell: testing, testing, testing the flight plan request
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors